An initial trial suggests lamivudine, an inexpensive oral drug for treating HIV, can improve vision in patients with diabetic macular edema more effectively and affordably than current therapies. Medscape Medical News
Author: Medscape
Irritant Contact Dermatitis
The patient’s medical history was significant for mild atopic dermatitis, well-controlled with triamcinolone ointment used intermittently, and a background of ichthyosis vulgaris. Medscape Dermatology
A Teen With a Progressive Rash on Her Face and Hands
The patient’s medical history was significant for mild atopic dermatitis, well-controlled with triamcinolone ointment used intermittently, and a background of ichthyosis vulgaris. Medscape Dermatology
Study Underscores Need for Eye Exam in Psych Disorders
An analysis of a large national database shows a diagnosis of bipolar disorder or major depressive disorder is linked to an increased risk for retinal diseases in middle-aged and older individuals. Medscape Medical News
US FDA Approves Alcon’s New Dry-eye Drug (May 28)
(This May 28 story has been corrected to say ‘eye drop,’ not ‘liquid medication,’ in paragraph 3 and to remove the picture) Reuters Health Information
US FDA Approves Alcon’s New Dry-eye Drug
(This May 28 story has been corrected to say ‘eye drop,’ not ‘liquid medication,’ in paragraph 3 and to remove the picture) Reuters Health Information
Can You Eat Away the Risk for Blindness?
Although cures for age-related macular degeneration are elusive, the case for prevention through nutrition looks strong and certainly better than a shot in the eye. Medscape Medical News
Intranasal Schirmer Test Shows Promise in Allergy Diagnosis
Objective measurement of nasal secretions may help clinicians diagnose allergic rhinitis. Medscape Medical News
Updated McDonald Criteria for MS Allow Earlier Dx and Tx
Drs Andrew Wilner and Oliver Tobin discuss key features of the updated McDonald criteria and how they change the diagnosis of multiple sclerosis. Medscape Neurology
Hidden Formula, High Stakes: Clinicians Push FDA on NarxCare
A band of clinicians and chronic pain advocates are pushing regulators to scrutinize a controversial risk rating tool. Medscape Medical News
Hidden Methods, High Stakes: Clinicians Push FDA on NarxCare
A band of clinicians and chronic pain advocates are pushing regulators to scrutinize a controversial risk rating tool. Medscape Medical News
Going to Mars? Your Body Might Disagree
Astronauts face severe health risks on their journey to Mars, dealing with muscle loss, vision changes, and immune system challenges. Medscape Medical News
Study: Dropless Cataract Surgery Slashes Drug Costs
Injection of an antibiotic and glucocorticoid after cataract surgery is far cheaper and as safe as a protocol 12 drops daily tapered over 4 weeks, a new study shows. Medscape Medical News
Office-Based Cataract Surgery Measures Up To ASC Cases
A retrospective review of 1300 cataract operations by one surgeon finds office-based surgeries are no less safe than ambulatory surgery center cases. Medscape Medical News
Safe Driving Possible Despite Loss of Visual Field
People who experience a reduced visual field as a result of glaucoma or stroke can drive as safely as those of the same age with normal vision, a recent study finds. Medscape Medical News
This Gender Logs More Eye Surgeries in Residency
Records from more than 4800 ophthalmology residents show the average number of cataract surgeries and other eye procedures could vary by gender and race or ethnicity. Medscape Medical News
ARVO Attendees Hear Call to Save National Eye Institute
An eye research advocacy group has issued an urgent plea to thwart proposals to gut federal funding for biomedical research and dismantle the National Eye Institute. Medscape Medical News
How Climate Change Threatens Eye Health
Cataracts, pink eye, and other ocular disorders are linked to heat, air pollution, and higher UV exposure. Knowable Magazine
Cataract Surgery May Be Safe Beyond A1c Cutoffs
Cataract surgery may not increase the risk for postoperative endophthalmitis or severe systemic adverse events in patients with diabetes, regardless of A1c levels, according to a recent study. Medscape Medical News
MHRA Approves First UK Treatment for Thyroid Eye Disease
The Medicines and Healthcare products Regulatory Agency has approved teprotumumab, the first treatment to be licensed in the UK for adults with thyroid eye disease. Medscape News UK